west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "LIU Aijun" 3 results
  • The Effects of Preventing Use Antibiotics on the Prognosis of Cirrhotic Patients with Gastrointestinal Hemorrhage

    目的:探讨预防性应用抗生素对肝硬化并发消化道出血预后的影响。方法:采用回顾性调查的研究方法,对肝硬化并发消化道出血共245 例应用抗生素情况及发生再次出血的关系进行分析。结果:预防性应用抗生素组82例1年内再出血23 例,占28.0 %;未用组163例1年内再出血77例,占47.2%,两组比较1年内再次出血率差异有统计学意义( Plt; 0.05) 。结论:预防性应用抗生素可以减少肝硬化并消化道出血患者一年内再次出血率。

    Release date:2016-09-08 09:54 Export PDF Favorites Scan
  • Efficacy and safety of TE regimen versus CEF regimen for Chinese women with TNM ⅡA to ⅢC stage breast cancer: a meta-analysis

    Objectives To systematically review the efficacy and safety of TE regimen versus CEF regimen for Chinese women with ⅡA to ⅢC stage breast cancer. Methods Databases including PubMed, EMbase, VIP, CNKI, WanFang Data and CBM were electronically searched from inception to December 2016 to collect randomized controlled trials (RCT) on TE regimen versus CEF regimen for Chinese women with ⅡA to ⅢC stage breast cancer. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of included studies. Then, meta-analysis was performed by using RevMan 5.3 software. Results A total of 14 RCTs were included. The results of meta-analysis showed that: the complete remission rate (CR) (RR=1.73, 95%CI 1.35 to 2.22, P<0.000 1) and clinical efficacy rate (RR) (RR=1.31, 95%CI 1.22 to 1.42,P<0.000 01) of the TE group were superior to those of the CEF group. But there were no significant differences between two groups in cardiac toxicity, myelosuppression and gastrointestinal reactions. Conclusions TE regimen is superior to CEF regimen in terms of efficacy for the Chinese women with ⅡA to ⅢC stage breast cancer, and there is no difference between the incidence of adverse reactions. Due to limited quality and quantity of the included studies, more high quality studies are required to verify above conclusions.

    Release date:2018-01-20 10:08 Export PDF Favorites Scan
  • Surgical treatment and mid-term results of functional single ventricle associated with total anomalous pulmonary venous connection

    ObjectiveTo evaluate the mid-term results of surgical treatment for functional single ventricle associated with total anomalous pulmonary venous connection.MethodsWe reviewed the clinical data and follow-up results of 12 patients in our hospital who underwent both single ventricle series palliation and total anomalous pulmonary venous connection correction from 2008 to 2018. There were 6 males and 6 females at age of 2.3 (1-21) years. Univariable and multivariable Cox proportional hazard regression methods were performed. The Kaplan-Meier method was used to estimate the survival rate.ResultsAll patients were successfully removed from extracorporeal circulation. The cardiopulmonary bypass time was 113.8±42.5 min. The myocardial block time was 57.7±31.7 min. There were 3 in-hospital deaths and 4 late deaths. The causes of death in hospital were pulmonary hypertension, pulmonary hemorrhage, and hypoxemia. During follow-up, the cause of death was heart failure. The survival rate at 1 year and 3 years was 58.3% (95%CI 27% to 80%) and 40% (95%CI 13% to 65%), respectively. Median follow-up was 48.3 months (range: 1 to 118 months).ConclusionFunctional single ventricle combined with complete pulmonary venous drainage is a serious clinical disease, with poor therapeutic effect and high overall mortality.

    Release date:2021-03-19 01:41 Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content